Delivery Order SPE2DB24D2205-SPE2DB25FEBJR

Award Date 4/23/25
Potential Completion Date 4/24/25
Potential Value $36K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $33,807.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,149.12 delivery order contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of April 23, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $11,021.92 and is a Firm Fixed Price Delivery Order for the supply of the drug COSENTYX UNOREADY 300 MG PEN 2ML. The contract has an ultimate completion date of April 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $13,315.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. The award has an ultimate completion date of January 16, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $2,518.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Defense Logistics Agency (DLA) awarded this Firm Fixed Price Delivery Order valued at $76,451.94 for the supply of COSENTYX UNOREADY 300 mg pen 2ml. The contract has an ultimate completion date of January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,195.71, is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $1,574.56 and is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML medical supplies. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 10, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of COSENTYX UNOREADY 300 MG PEN 2ML. The award, valued at $3,126.41, has a firm fixed price and an ultimate completion date of August 19, 2024. The contract is not set aside. As a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, Amerisourcebergen holds several Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $54,132.57, is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML medical products. The contract has an ultimate completion date of December 31, 2024 and is a Firm Fixed Price Delivery Order. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FEBJR
    Delivery Order

This federal contract award, valued at $35,609.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of April 24, 2025. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA, valued at $999,999,999.00. The IDC, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 7/23/25, 9:45 AM